These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2417705)
1. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia. Zimm S; Reaman G; Murphy RF; Poplack DG Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705 [TBL] [Abstract][Full Text] [Related]
2. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene. Graf LH; McRoberts JA; Harrison TM; Martin DW J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676 [TBL] [Abstract][Full Text] [Related]
3. Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia. Lennard L; Hale JP; Lilleyman JS Br J Clin Pharmacol; 1993 Oct; 36(4):277-84. PubMed ID: 12959304 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of 6-mercaptopurine in human leukemic cells. Higuchi T; Nakamura T; Wakisaka G Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607 [TBL] [Abstract][Full Text] [Related]
5. Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome. Allsop J; Watts RW J Neurol Sci; 1980 May; 46(2):221-32. PubMed ID: 6155447 [TBL] [Abstract][Full Text] [Related]
6. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Zimm S; Johnson GE; Chabner BA; Poplack DG Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397 [TBL] [Abstract][Full Text] [Related]
7. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro. Liliemark J; Pettersson B; Peterson C Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210 [TBL] [Abstract][Full Text] [Related]
8. Phosphoribosylpyrophosphate synthesis in cultured human cells. Benke PJ; Dittmar D Science; 1977 Dec; 198(4322):1171-3. PubMed ID: 201027 [TBL] [Abstract][Full Text] [Related]
10. Correlation of enhanced 6-mercaptopurine cytotoxicity with increased phosphoribosylpyrophosphate levels in Chinese hamster ovary cells treated with 3-aminobenzamide. Moses K; Willmore E; Harris AL; Durkacz BW Cancer Res; 1990 Apr; 50(7):1992-6. PubMed ID: 1690594 [TBL] [Abstract][Full Text] [Related]
11. Kinetic mechanism of human hypoxanthine-guanine phosphoribosyltransferase: rapid phosphoribosyl transfer chemistry. Xu Y; Eads J; Sacchettini JC; Grubmeyer C Biochemistry; 1997 Mar; 36(12):3700-12. PubMed ID: 9132023 [TBL] [Abstract][Full Text] [Related]
12. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia. Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360 [TBL] [Abstract][Full Text] [Related]
13. Application of HPLC to study the kinetics of a branched bi-enzyme system consisting of hypoxanthine-guanine phosphoribosyltransferase and xanthine oxidase--an important biochemical system to evaluate the efficiency of the anticancer drug 6-mercaptopurine in ALL cell line. Kalra S; Paul MK; Balaram H; Mukhopadhyay AK J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):7-14. PubMed ID: 17081813 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity. Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145 [TBL] [Abstract][Full Text] [Related]
15. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts. Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339 [TBL] [Abstract][Full Text] [Related]
16. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667 [TBL] [Abstract][Full Text] [Related]
17. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines. Fotoohi AK; Lindqvist M; Peterson C; Albertioni F Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731 [TBL] [Abstract][Full Text] [Related]
18. Induction of millimolar amounts of 5-phosphoribosyl-1-pyrophosphate in human erythrocytes by incubation in inosine-pyruvate-phosphate medium. A 31P-NMR study. Petersen A; Quistorff B Biomed Biochim Acta; 1990; 49(2-3):S111-6. PubMed ID: 1696811 [TBL] [Abstract][Full Text] [Related]
19. Interrelationship of number of glucose carriers and intracellular phosphoribosyl diphosphate level of Ehrlich ascites tumor cells in vitro. Choy YM; Lam WP; Fung KP Cancer Biochem Biophys; 1988 Nov; 10(2):141-7. PubMed ID: 2472871 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of 6-mercaptopurine in human leukemic cells and phosphoribosylpyrophosphate. Higuchi T Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):248-58. PubMed ID: 1243219 [No Abstract] [Full Text] [Related] [Next] [New Search]